To ensure metered dose inhalers (MDIs) product quality and performance, studies are required to verify that the critical quality attributes (CQAs) are met in the finished product to support design “verification” and “validation”. 

In this webinar, our expert, Eamonn Coughlan, describes the tests required, the regulatory context and considerations for robust design verification that helps to determine if a MDI product safely and effectively meets user needs and achieves its intended effects.

Please complete the form to watch our recorded webinar now: